Neuroprotection in late life attention-deficit/hyperactivity disorder: A review of pharmacotherapy and phenotype across the lifespan is a research paper published in Frontiers in Human Neuroscience (2022). On theSindex it has a DataRank of 0.318. It has been cited 6 times, with 6 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0.0256
From 2 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 6 citers.
Brain and Behavior Research Foundation
Grant: NARSAD Young Investigator Grant
National Institutes of Health
Grant: K01 Grant (1MH110645)
King Abdullah University of Science and Technology
Grant: Baseline Funds
NIMH NIH HHS
Grant: K01 MH110645
National Institutes of Health
Grant: 5K01MH110645-02
Structural and Functional Biomarkers of Attention-Deficit/Hyperactivity Disorder
FWCI
0.56
Citation Percentile
0.6%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals